Skip to content

Shanghai Haoyuan Chemexpress Co Ltd Sustainability Reports

The company researches, develops, and manufactures pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and small molecule drugs. It specializes in offering CRO and CDMO services covering organic synthesis, process development, and industrial applications for the global biomedical industry.

Sector: Manufacturing

Country: China

Exchange: Shanghai Stock Exchange

FIGI: BBG00V3FWTX9

5 reports from 2023 to 2025